Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
Journal of the American Chemical Society|January 22, 2026
An Engineered Nanovesicles-Based Lysosome-Targeting Protein Degradation Platform (NV-TACs) for Cancer ImmunotherapyYoumei Xiao, Xiuman Zhou, Xiaoshuang Niu, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|April 24, 2025
DON-Loaded Nanodrug-T Cell Conjugates With PD-L1 Blockade for Solid Tumor TherapyXin Yang, Xiaoshuang Niu, Ye Su, et al.
Acta Pharmaceutica Sinica. B|March 15, 2024
Development of LAG-3/FGL1 blocking peptide and combination with radiotherapy for cancer immunotherapyYuzhen Qian, Yixuan Sun, Peishang Shi, et al.
Cancer Immunology, Immunotherapy : CII|February 11, 2025
Chidamide functions as a VISTA/PSGL-1 blocker for cancer immunotherapyXiaoshuang Niu, Wenshan Zhao, Xiuman Zhou, et al.
International Journal of Clinical and Experimental Medicine|January 1, 2015
Replication of association of nine susceptibility loci with Graves' disease in the Chinese Han populationWenhua Du, Cuige Liang, Fengyuan Che, et al.
Science China. Life Sciences|February 7, 2024
Hemin blocks TIGIT/PVR interaction and induces ferroptosis to elicit synergistic effects of cancer immunotherapyXiaowen Zhou, Yang Li, Xiangrui Zhang, et al.
Nature Communications|April 21, 2023
Polyfluorinated crosslinker-based solid polymer electrolytes for long-cycling 4.5 V lithium metal batteriesLingfei Tang, Bowen Chen, Zhonghan Zhang, et al.
Pageof 4